Effect of age on recovery from remifentanil anaesthesia

Anaesthesia and Intensive Care

Volumn 29, Issue 5, 2001, Pages 506-509

  Lai, A ^a   Hung, C T ^a  

^a QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

Anaesthesia age; Anaesthetics; Intravenous: remifentanil; Pharmacodynamics; Pharmacokinetics; Recovery

Indexed keywords

ATROPINE; BENZODIAZEPINE; CLONIDINE; MORPHINE; NEOSTIGMINE; NITROUS OXIDE; OPIATE; OXYGEN; PROPOFOL; REMIFENTANIL; TRICYCLIC ANTIDEPRESSANT AGENT; VECURONIUM;

ADULT; AGE; AGED; ANESTHESIA INDUCTION; ANESTHETIC RECOVERY; ARTICLE; BOLUS INJECTION; BRADYCARDIA; BREATHING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COVARIANCE; DRUG INFUSION; ENDOTRACHEAL TUBE; EVALUATION; EXTUBATION; EYE MOVEMENT; FEMALE; HUMAN; INTRAOPERATIVE PERIOD; LAPAROTOMY; LIMB MOVEMENT; MAINTENANCE THERAPY; MALE; NAUSEA AND VOMITING; PATIENT CODING; PATIENT CONTROLLED ANALGESIA; PERIOPERATIVE PERIOD; POSTOPERATIVE PAIN; PROSPECTIVE STUDY; PRURITUS; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RECOVERY ROOM; SCORING SYSTEM; STATISTICAL ANALYSIS; STIMULATION; TIME; TITRIMETRY; WARD;

EID: 0034785793     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x0102900510     Document Type: Article

References (14)

1. Opioid receptor activity of GI87084B, a novel ultra short acting analgesic, in isolated tissues
2. The pharmacokinetics of the new short acting opioid remifentanil (GI 87084B) in healthy adult male volunteers
3. Preliminary pharmacokinetics and pharmacodynamics of an ultra short acting opioid, remifentanil (GI 87084B)
4. Pharmacokinetics of remifentanil (GI 87084B) and its major metabolite (GI 90291) in patients undergoing elective inpatient surgery
5. Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteers
6. Remifentanil and anesthesia for the future
7. Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease
8. Respiratory effects of remifentanil in subjects with severe renal impairment compared to matched controls
9. A comparison of remifentanil and alfentanil in patients undergoing major abdominal surgery
10. Initial clinical experience with remifentanil, a new opioid metabolized by esterases
11. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development
12. Population pharmacodynamics and pharmacokinetics of remifentanil as a supplement to nitrous oxide anesthesia for elective abdominal surgery
13. Sex differences in speed of emergence and quality of recovery after anaesthesia: Cohort study
14. Women emerge from general anaesthesia with propofol/alfentanil/nitrous oxide faster than men